1. Executive Summary

2. Anti-Parkinson Drugs Market Characteristics

3. Anti-Parkinson Drugs Market Trends And Strategies

4. Impact Of COVID-19 On Anti-Parkinson Drugs

5. Anti-Parkinson Drugs Market Size And Growth
5.1. Global Anti-Parkinson Drugs Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Anti-Parkinson Drugs Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Anti-Parkinson Drugs Market Segmentation
6.1. Global Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Levodopa/Carbidopa
Dopamine Receptor Agonists
Monoamine Oxidase Type B (MAO-B) Inhibitors
Catechol-O-Methyltransferase (COMT)-inhibitors
Anticholinergics
Other Drugs
6.2. Global Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Oral
Injection
Transdermal
6.3. Global Anti-Parkinson Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Hospital Pharmacies
Retailer Pharmacies
Online Pharmacies

7. Anti-Parkinson Drugs Market Regional And Country Analysis
7.1. Global Anti-Parkinson Drugs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Anti-Parkinson Drugs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Anti-Parkinson Drugs Market
8.1. Asia-Pacific Anti-Parkinson Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Anti-Parkinson Drugs Market
9.1. China Anti-Parkinson Drugs Market Overview
9.2. China Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Anti-Parkinson Drugs Market
10.1. India Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Anti-Parkinson Drugs Market
11.1. Japan Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Anti-Parkinson Drugs Market
12.1. Australia Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Anti-Parkinson Drugs Market
13.1. Indonesia Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Anti-Parkinson Drugs Market
14.1. South Korea Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Anti-Parkinson Drugs Market
15.1. Western Europe Anti-Parkinson Drugs Market Overview
15.2. Western Europe Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Anti-Parkinson Drugs Market
16.1. UK Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Anti-Parkinson Drugs Market
17.1. Germany Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Anti-Parkinson Drugs Market
18.4. France Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.5. France Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Anti-Parkinson Drugs Market
19.1. Eastern Europe Anti-Parkinson Drugs Market Overview
19.2. Eastern Europe Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Anti-Parkinson Drugs Market
20.1. Russia Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Anti-Parkinson Drugs Market
21.1. North America Anti-Parkinson Drugs Market Overview
21.2. North America Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Anti-Parkinson Drugs Market
22.1. USA Anti-Parkinson Drugs Market Overview
22.2. USA Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Anti-Parkinson Drugs Market
23.1. South America Anti-Parkinson Drugs Market Overview
23.2. South America Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Anti-Parkinson Drugs Market
24.1. Brazil Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Anti-Parkinson Drugs Market
25.1. Middle East Anti-Parkinson Drugs Market Overview
25.2. Middle East Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Anti-Parkinson Drugs Market
26.1. Africa Anti-Parkinson Drugs Market Overview
26.2. Africa Anti-Parkinson Drugs Market, Segmentation By Drugs Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Anti-Parkinson Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Anti-Parkinson Drugs Market Competitive Landscape And Company Profiles
27.1. Anti-Parkinson Drugs Market Competitive Landscape
27.2. Anti-Parkinson Drugs Market Company Profiles
27.2.1. GlaxoSmithKline plc
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Pfizer
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Merck
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Novartis
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Roche
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Anti-Parkinson Drugs Pipeline Analysis

29. Key Mergers And Acquisitions In The Anti-Parkinson Drugs Market

30. Anti-Parkinson Drugs Market Future Outlook and Potential Analysis

31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.5. Copyright And Disclaimer

Companies Mentioned
GlaxoSmithKline plc.
Pfizer
Merck
Novartis
Roche
UCB S.A.
Teva Pharmaceuticals
AbbVie Inc.
Mylan
Boehringer Ingelheim
Orion Pharma
ACADIA Pharmaceuticals Inc.
Sun Pharma
Wockhardt
Dr. Reddy's
Intas
US WorldMeds
Zydus Cadila
Cipla
Strides
1 A Pharma
Upsher-Smith
Lundbeck
Vertical Pharmaceuticals, LLC
Zambon Pharmaceuticals
M Somerset Pharmaceuticals Inc.
Wockhardt